Scarica l'app Stockscreener
231.10
0.50%
-1.16
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché THC Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$232.26
Aprire:
$231.16
Volume 24 ore:
1.14M
Relative Volume:
1.15
Capitalizzazione di mercato:
$20.31B
Reddito:
$20.69B
Utile/perdita netta:
$2.40B
Rapporto P/E:
14.79
EPS:
15.6208
Flusso di cassa netto:
$1.55B
1 W Prestazione:
+14.76%
1M Prestazione:
+16.02%
6M Prestazione:
+34.46%
1 anno Prestazione:
+73.02%
Intervallo 1D:
$227.48
$235.50
Intervallo di 1 settimana:
$186.50
$235.77
Portata 52W:
$109.82
$235.77
Tenet Healthcare Corp Stock (THC) Company Profile
Nome
Tenet Healthcare Corp
Settore
Industria
Telefono
469-893-2200
Indirizzo
14201 DALLAS PARKWAY, DALLAS, TX
Compare THC vs HCA, UHS, FMS, ENSG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
THC
Tenet Healthcare Corp
|
231.10 | 20.41B | 20.69B | 2.40B | 1.55B | 15.62 |
|
HCA
Hca Healthcare Inc
|
540.29 | 119.69B | 75.60B | 7.78B | 7.69B | 28.38 |
|
UHS
Universal Health Services Inc
|
234.81 | 14.62B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.44 | 14.18B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
213.34 | 12.46B | 4.11B | 239.98M | 193.10M | 4.12 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Ripresa | Goldman | Buy |
| 2025-07-28 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-05-29 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Iniziato | Morgan Stanley | Overweight |
| 2025-02-26 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-12-16 | Downgrade | Goldman | Buy → Neutral |
| 2024-11-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-27 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Iniziato | JP Morgan | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-03-29 | Iniziato | Wells Fargo | Overweight |
| 2022-02-10 | Aggiornamento | UBS | Neutral → Buy |
| 2022-02-09 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Aggiornamento | Truist | Hold → Buy |
| 2022-01-20 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Ripresa | Citigroup | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-09-24 | Iniziato | UBS | Neutral |
| 2021-08-12 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Ripresa | Citigroup | Buy |
| 2021-07-09 | Iniziato | Seaport Global Securities | Buy |
| 2021-05-03 | Ripresa | Goldman | Buy |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-01-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-15 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Aggiornamento | UBS | Neutral → Buy |
| 2019-11-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Ripresa | Goldman | Neutral |
| 2019-02-26 | Reiterato | BofA/Merrill | Neutral |
| 2019-01-14 | Iniziato | Stephens | Equal-Weight |
| 2019-01-03 | Iniziato | Deutsche Bank | Hold |
| 2018-12-17 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Iniziato | UBS | Neutral |
| 2018-06-29 | Downgrade | Jefferies | Buy → Hold |
| 2018-03-23 | Ripresa | Mizuho | Buy |
| 2018-01-30 | Ripresa | Wells Fargo | Market Perform |
| 2018-01-03 | Iniziato | Goldman | Neutral |
| 2017-12-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Reiterato | Mizuho | Neutral |
| 2017-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Tenet Healthcare Corp Borsa (THC) Ultime notizie
Tenet Healthcare Corporation $THC Position Trimmed by LSV Asset Management - MarketBeat
Rhumbline Advisers Has $48.46 Million Stake in Tenet Healthcare Corporation $THC - MarketBeat
ING Groep NV Sells 24,400 Shares of Tenet Healthcare Corporation $THC - MarketBeat
Barclays Raises Price Target for Tenet Healthcare (THC) to $257 - GuruFocus
Guggenheim raises Tenet Healthcare stock price target on strong 2026 guidance - Investing.com
THC: Guggenheim Raises Price Target for Tenet Healthcare | THC S - GuruFocus
Jefferies Raises Price Target for Tenet Healthcare (THC) to $265 - GuruFocus
UBS Raises Price Target for Tenet Healthcare (THC) to $288 | THC Stock News - GuruFocus
Tenet Healthcare Beats Q4 Earnings: But 2026 EBITDA Margin May Decline - Yahoo Finance
Tenet Healthcare stock price target raised to $250 from $225 at KeyBanc By Investing.com - Investing.com South Africa
THC: Keybanc Raises Price Target for Tenet Healthcare to $250 | - GuruFocus
Jefferies raises Tenet Healthcare stock price target to $265 on growth outlook - Investing.com
Tenet Healthcare Corporation (NYSE:THC) Q4 2025 Earnings Call Transcript - Insider Monkey
Tenet Healthcare stock price target raised to $250 from $225 at KeyBanc - Investing.com
THC Q4 Deep Dive: Tech-Driven Efficiency and Ambulatory Expansion Offset Exchange Headwinds - Finviz
Is It Too Late To Consider Tenet Healthcare (THC) After A 79% One Year Surge? - Yahoo Finance
Tenet Healthcare Q4 Earnings Call Highlights - Yahoo Finance
Tenet Healthcare Earnings Call Balances Growth and Risks - TipRanks
Tenet: Q4 Financial Results Overview - Bitget
Tenet Healthcare Corp (THC) Q4 2025 Earnings Call Highlights: St - GuruFocus
Tenet Looks Likely To Fend Off Many Upcoming Headwinds - Morningstar
Tenet Healthcare Expands with $1.9B Conifer Deal and Strong Profit Outlook - StocksToTrade
Tenet Healthcare stock price today: THC jumps 16% after Q4 results, 2026 outlook - TechStock²
Tenet Healthcare’s Strategic Deal With CommonSpirit Boosts Growth Forecast - StocksToTrade
Tenet Healthcare shares steady after strong Q4, upbeat 2026 outlook - AlphaStreet News
Tenet Healthcare stock hits all-time high of 222.83 USD - Investing.com
Tenet Healthcare Quarterly Profit Surges As Hospital, Surgery Demand Grows - Benzinga
Tenet Healthcare (NYSE:THC) Shares Up 11.8% Following Strong Earnings - MarketBeat
Tenet Healthcare Q4 2025 presentation: 13% EBITDA growth, balance sheet strengthens - Investing.com
Tenet Healthcare (THC) Q4 2025 Earnings Transcript - The Globe and Mail
Earnings call transcript: Tenet Healthcare Q4 2025 beats earnings expectations - Investing.com
Tenet Healthcare (NYSE:THC) Announces Quarterly Earnings Results - MarketBeat
Tenet Healthcare Q4 Earnings Summary & Key Takeaways - Benzinga
Tenet Healthcare reports Q4 adjusted EPS $4.70, consensus $4.05 - TipRanks
Tenet Healthcare (NYSE:THC) Surprises With Q4 CY2025 Sales - Finviz
Tenet Healthcare (THC) Exceeds Q4 Revenue Expectations - GuruFocus
Tenet Healthcare (THC) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Guggenheim Keeps Their Buy Rating on Tenet Healthcare (THC) - The Globe and Mail
Tenet Healthcare Corp (NYSE:THC) Reports Strong Q4 2025 Earnings Beat and Provides 2026 Outlook - ChartMill
Tenet Healthcare beats Q4 expectations, issues solid 2026 outlook By Investing.com - Investing.com South Africa
Tenet Healthcare Corp. Profit Advances In Q4 - Nasdaq
Tenet Healthcare beats Q4 expectations, issues solid 2026 outlook - Investing.com
Tenet: Q4 Earnings Snapshot - KTEN
Tenet Healthcare earnings beat by $0.68, revenue topped estimates - Investing.com
Tenet Healthcare Corporation Reports Strong Q4 and FY 2025 Results - TradingView
Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook - Yahoo Finance
Will Lower Patient Days Affect Tenet Healthcare's Q4 Earnings? - Finviz
Preview: Tenet Healthcare's Earnings - Benzinga
Tenet Healthcare (THC) Q4 Earnings: What To Expect - Finviz
Tenet Healthcare (THC) Valuation Check After Mixed Short Term Returns And Strong Multi Year Performance - Yahoo Finance
Tenet Healthcare (THC) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Tenet Healthcare Corp Azioni (THC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.32%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):